Loading...

XML

Word

Printable

Solution:

Hide
Thank you for your question regarding CMS506v6 Safe Use of Opioids - Concurrent Prescribing. The opioids and benzodiazepines which are relevant to this measure can be found in the following value sets: "Schedule II & III Opioid Medications (OID 2.16.840.1.113762.1.4.1111.165) and "Schedule IV Benzodiazepines" (OID 2.16.840.1.113762.1.4.1125.1). You can reference the applicable codes contained in these value sets on the Value Set Authority Center (VSAC) at https://vsac.nlm.nih.gov/. Click on the “Search Value Sets” tab and enter the value set ID to review codes included in the respective value set.

Show
Thank you for your question regarding CMS506v6 Safe Use of Opioids - Concurrent Prescribing. The opioids and benzodiazepines which are relevant to this measure can be found in the following value sets: "Schedule II & III Opioid Medications (OID 2.16.840.1.113762.1.4.1111.165) and "Schedule IV Benzodiazepines" (OID 2.16.840.1.113762.1.4.1125.1). You can reference the applicable codes contained in these value sets on the Value Set Authority Center (VSAC) at https://vsac.nlm.nih.gov/ . Click on the “Search Value Sets” tab and enter the value set ID to review codes included in the respective value set.
2024 Reporting Period EH/CAH eCQMs:

CMS0506v6
Impact:
appropriate med list that impacts the population criteria

Are these meds included as an Opioid and Benzo for 2024 Reporting period for CMS 506v6?

Thank you.

Opioid	Benzo
oxyCODONE 5 mg/5 mL solution	diazePAM 5 MG/5ML SOLN
HYDROmorphone, PF, 500 MG/50ML injection	clonazePAM 0.1 mg/mL suspension
methadone 10 MG/5ML solution	clonazePAM 0.1 mg/mL suspension
oxyCODONE 5 mg/5 mL solution	midazolam (NAYZILAM) 5 mg/0.1 mL nasal spray
morphine 10 mg/5mL solution	VALTOCO 10 MG DOSE 10 MG/0.1ML nasal spray